James A. Feinstein

4.4k total citations · 1 hit paper
79 papers, 2.9k citations indexed

About

James A. Feinstein is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and General Health Professions. According to data from OpenAlex, James A. Feinstein has authored 79 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pediatrics, Perinatology and Child Health, 22 papers in Geriatrics and Gerontology and 12 papers in General Health Professions. Recurrent topics in James A. Feinstein's work include Pharmaceutical studies and practices (25 papers), Pharmaceutical Practices and Patient Outcomes (22 papers) and Childhood Cancer Survivors' Quality of Life (14 papers). James A. Feinstein is often cited by papers focused on Pharmaceutical studies and practices (25 papers), Pharmaceutical Practices and Patient Outcomes (22 papers) and Childhood Cancer Survivors' Quality of Life (14 papers). James A. Feinstein collaborates with scholars based in United States, Canada and United Kingdom. James A. Feinstein's co-authors include Chris Feudtner, Dingwei Dai, Wenjun Zhong, Matt Hall, Allison B. Blackmer, Tammy I. Kang, Allison Kempe, Huaqing Zhao, Jon M. Burnham and Xianqun Luan and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

James A. Feinstein

72 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation

2014 1.3k citations Chris Feudtner, James A. Feinstein et al. BMC Pediatrics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James A. Feinstein United States	23	1.1k	542	469	464	439	79	2.9k
Wenjun Zhong United States	16	505 0.5×	482 0.9×	341 0.7×	387 0.8×	408 0.9×	45	2.3k
Marianne Weiss United States	29	754 0.7×	279 0.5×	596 1.3×	726 1.6×	1.1k 2.6×	113	3.2k
Daisy Goodman United States	19	606 0.6×	372 0.7×	858 1.8×	392 0.8×	896 2.0×	42	3.0k
Henk F. van Stel Netherlands	28	281 0.3×	290 0.5×	379 0.8×	380 0.8×	622 1.4×	84	2.7k
James M. Chamberlain United States	30	912 0.9×	561 1.0×	584 1.2×	721 1.6×	409 0.9×	131	3.3k
Helle Wallach‐Kildemoes Denmark	14	351 0.3×	645 1.2×	578 1.2×	113 0.2×	389 0.9×	34	3.8k
Louise Rose Canada	41	437 0.4×	389 0.7×	719 1.5×	838 1.8×	612 1.4×	274	5.3k
Harold K. Simon United States	36	615 0.6×	603 1.1×	712 1.5×	1.2k 2.5×	749 1.7×	163	4.2k
Pamela J. Schoettker United States	29	318 0.3×	531 1.0×	274 0.6×	399 0.9×	621 1.4×	70	2.1k
James C. Gay United States	27	459 0.4×	407 0.8×	207 0.4×	759 1.6×	692 1.6×	96	2.6k

Countries citing papers authored by James A. Feinstein

Since Specialization

Citations

This map shows the geographic impact of James A. Feinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Feinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Feinstein more than expected).

Fields of papers citing papers by James A. Feinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Feinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Feinstein. The network helps show where James A. Feinstein may publish in the future.

Co-authorship network of co-authors of James A. Feinstein

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Feinstein. A scholar is included among the top collaborators of James A. Feinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Feinstein. James A. Feinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feinstein, James A., et al.. (2025). How healthcare organizations provide disability accommodations to promote equitable care: A qualitative study. Disability and health journal. 18(3). 101823–101823.

Hachem, May El, Tamara Caldaro, Irene Lara‐Corrales, et al.. (2025). Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline. British Journal of Dermatology. 193(3). 394–404.

Girdwood, Sonya Tang, Matt Hall, James W. Antoon, et al.. (2024). Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid. JAMA Network Open. 7(2). e2355707–e2355707. 1 indexed citations

Werner, Nicole E., et al.. (2024). Effectiveness of a Mobile App (Meds@HOME) to Improve Medication Safety for Children With Medical Complexity: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 13. e60621–e60621.

Lucky, Anne W., Kristen P. Hook, Anna L. Bruckner, et al.. (2023). Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa. Pediatric Dermatology. 40(5). 863–865. 3 indexed citations

Antoon, James W., et al.. (2023). Advancing pediatric medication safety using real‐world data: Current problems and potential solutions. Journal of Hospital Medicine. 18(9). 865–869. 2 indexed citations

Feinstein, James A., Peter J. Gill, & Brett R. Anderson. (2023). Preparing for the International Classification of Diseases, 11th Revision (ICD-11) in the US Health Care System. JAMA Health Forum. 4(7). e232253–e232253. 15 indexed citations

Liy‐Wong, Carmen, Cristina Tarango, Elena Pope, et al.. (2023). Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. Orphanet Journal of Rare Diseases. 18(1). 38–38. 7 indexed citations

Coller, Ryan J., et al.. (2023). An mHealth Design to Promote Medication Safety in Children with Medical Complexity. Applied Clinical Informatics. 15(1). 45–54. 7 indexed citations

10.

Feinstein, James A., et al.. (2022). Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children. Journal of Pain and Symptom Management. 65(2). e109–e114. 2 indexed citations

11.

Feinstein, James A., et al.. (2022). Making Polypharmacy Safer for Children with Medical Complexity. The Journal of Pediatrics. 254. 4–10. 7 indexed citations

12.

Feinstein, James A.. (2021). Long-Term Outcomes in Children with Pediatric Inflammatory Multisystem Syndrome. Journal watch. 2021. 1 indexed citations

13.

Nelson, Katherine, Catherine Diskin, Joanna Thomson, et al.. (2021). Validation of Neurologic Impairment Diagnosis Codes as Signifying Documented Functional Impairment in Hospitalized Children. Academic Pediatrics. 22(5). 782–788. 7 indexed citations

14.

Bettenhausen, Jessica L., Matt Hall, Stephanie K. Doupnik, et al.. (2020). Hospitalization Outcomes for Rural Children with Mental Health Conditions. The Journal of Pediatrics. 229. 240–246.e1. 5 indexed citations

15.

Doupnik, Stephanie K., Jonathan Rodean, James A. Feinstein, et al.. (2020). Health Care Utilization and Spending for Children With Mental Health Conditions in Medicaid. Academic Pediatrics. 20(5). 678–686. 26 indexed citations

16.

Bakaki, Paul M., Neal V. Dawson, Almut G. Winterstein, et al.. (2018). Defining pediatric polypharmacy: A scoping review. PLoS ONE. 13(11). e0208047–e0208047. 50 indexed citations

17.

Feinstein, James A., et al.. (2014). The concordance of endoscopic and histologic findings of 1000 pediatric EGDs. Gastrointestinal Endoscopy. 81(6). 1385–1391. 24 indexed citations

18.

Feudtner, Chris, James A. Feinstein, Wenjun Zhong, Matt Hall, & Dingwei Dai. (2014). Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatrics. 14(1). 199–199. 1292 indexed citations breakdown →

19.

Feinstein, James A., et al.. (2013). Diagnostic yield of EGD in children: a retrospective single-center study of 1000 cases. Gastrointestinal Endoscopy. 78(1). 47–54.e1. 36 indexed citations

20.

Bair‐Merritt, Megan, Chris Feudtner, A. Russell Localio, et al.. (2008). Health Care Use of Children Whose Female Caregivers Have Intimate Partner Violence Histories. Archives of Pediatrics and Adolescent Medicine. 162(2). 134–134. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact